Senators Question FDA’s Proposed Progressive Approval Pathway For Devices

US Democratic Sens. Elizabeth Warren of Massachusetts and Patty Murray of Washington State recently sent a letter to FDA officials Brett Giroir and Jeff Shuren that raises doubts about a planned bill calling for a progressive approval pathway for medical devices.

FDASignBldg21Entrance_1200x675

Two US senators have sent a letter to US Food and Drug Administration officials that raises new concerns about the agency’s legislative plan for a conditional progressive approval pathway for medical devices.

Democrats Elizabeth Warren of Massachusetts and Patty Murray of Washington State – both members of the Senate Health, Education, Labor and Pensions (HELP) Committee – said in their 4 November...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Regulation

More from Policy & Regulation